简体
  • 简体中文
  • 繁体中文
×

热门资讯> 正文

Alaunos Therapeutics股价因200万美元股票发行而下滑

2025-06-23 20:45

  • Alaunos Therapeutics (NASDAQ:TCRT) shares fell over 14% premarket on Monday after the company launched an equity offering to raise around $2M in proceeds.
  • The offering comprises 610,399 shares of common stock (or pre-funded warrants in lieu thereof) issued at a purchase price of $3.36 per share (or pre-funded warrant in lieu thereof)
  • The company currently intends to use the net proceeds of around $1.9M from the offering for its obesity program and general corporate purposes. The transaction is expected to close on or about June 24, 2025, subject to the satisfaction of customary closing conditions.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
问答大全
（工作日09：30 - 次日05：30）
客户端：
关注我们：
  • 微信公众号二维码

© 2025 深圳市时代华盛网络科技有限公司版权所有 粤ICP备16068286号